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Proteolytic enzymes active  at pH 7,  including  proteinases  and peptidases, 
have  been  prepared  from  serum  (1,  2),  polymorphonuclear  leucocytes  (3), 
pancreas  (4)  and  other  tissues,  various  plants  (including  payaya),  yeasts, 
molds,  and bacteria  (references cited in reference 5). Many of the proteinases 
are known to be inhibited by substances  of biological  importance.  Trypsin is 
inhibited  strongly  by serum  (6),  by a  crystalline  polypeptide prepared  from 
pancreas ~ (7), by a non-protein  compound,  perhaps a polypeptide,  crystallized 
in small amounts from blood  J (8, 9), by a mucoprotein prepared from egg white  j 
(10), by a globulin  crystallized  from soy bean ~ (11), and by a pseudoglobulin 
prepared from lima bean  J (12). Trypsin is also inhibited  by high concentrations 
of oxidizing  and reducing  agents  (5), heparin  (13),  and numerous  other sub- 
stances (references cited in reference 5). Serum proteinase is inhibited by serum 
(1,  14), by pancreatic  (14,  15) and soy bean  (16)  inhibitors,  and by heparinin 
sufficient concentration  (17).  Leucoproteinase  is inhibited  strongly  by  serum 
(3), and to a lesser extent by  reducing  agents,  p-aminobenzoic  acid,  sulfon- 
amides,  and  sulfonesi  but  not by  egg  white inhibitor  (5).  Papain  and most 
cathepsins  are markedly  inhibited  by  oxidizing  agents  and  other  sulfhydryl 
inhibitors,  and activated by reducing agents (18). Papain is inhibited to a lesser 
extent by serum  (5). 
1 Some properties of 
Source of inhibitor 
Pancreas 
Blood 
Lima bean 
Soy bean 
Egg white 
tioleculal 
weight 
6,000 
? 
10,000 
24,000 
29,000 
,hese inhibitors are summarized below (from references 7-12) : 
Nature of molecule 
Polypeptide  (crystal- 
lized) 
Polypeptide  ? 
Pseudoglobulin  protein 
Globulin  protein  (crys- 
taUized) 
Mucoprotein  (ovomu- 
cold) 
Reversibility 
of trypsin 
inhibition 
Reversible 
? 
? 
Irreversible 
Reversible 
Heat 
stability 
Yes 
No 
Yes 
Diffusibility 
through 
cellophane 
Slowly 
Yes 
? 
No 
No 
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The inhibition  of proteinolytic enzymes by serum has been  the subject of 
numerous  investigations,  but  the  components  of serum  responsible  for  this 
inhibition have not yet been identified  (9). In the studies to be reported here 
an effort has been made to characterize some of the proteinase-inhibitory com- 
ponents of the serum,  and to compare their actions with  those of proteinase 
inhibitors prepared from other sources. A  study has been made of the inhibi- 
tion of crystalline trypsin,  ~ serum proteinase, leucoproteinase, and papain by: 
(a)  Pancreatic,  2 soy bean, 2 lima bean, 3 and  egg white  8  inhibitors.  (b)  Serum 
and  plasma  (normal  human,  pooled),  and  purified plasma protein  fractions 
(human). 4 (c)  Oxidizing and reducing agents,  and mercurial sulfhydryl inhib- 
itors.  In addition,  some observations have  been made  on  the  activation  of 
serum  proteinase. 
Methods 
Preparation of Serum Proteinase.--Serum proteinase was prepared by both chloro- 
form and streptokinase activation of the inactive precursor present in serum (normal 
human, pooled), and in plasma protein fraction II +III. 
Serum proteinase precursor was prepared by dialysis of serum for 24 hours against 
running tap water, followed by dilution with 2 volumes of distilled water and acidifica- 
tion with acetic acid to pH 5.3, centrifugation of resulting precipitate, and redissolving 
in a volume of 1/100 ~  phosphate-buffered normal saline at pH 7.4 equal to 1/10 of 
the original serum volume (19). 
Streptokinase was prepared by Seitz filtration of an 18 hour culture of a "fibrino- 
lytic" strain of group A t~-hemolytic streptococci in beef-heart infusion containing 0.05 
per cent glucose, precipitation of the streptokinase with alcohol, and redissolving  in 
1/100 M phosphate-buffered normal saline at pH 7.4 equal to 1/4 the volume of the in- 
fusion (20). 
Chloroform-activated serum proteinase was prepared by shaking plasma (normal 
human, pooled) with 1/10 volume of chloroform for 2 minutes, and allowing the result- 
ing mixture to stand at room temperature for a week. The denatured proteins were 
removed by centrifugation and the supernatant was then treated as in the preparation 
of serum proteinase precursor (2). 
Preparation of Leucoproteinase.--The leucoproteinase  preparations  consisted  of 
homogenates of polymorphonuclear leucocytes (rat and  cat). These were  obtained 
from sterile exudates produced by the pleural and peritoneal injection of 3 ml. (rat) 
or 10 ml. (eat) of 5 per cent aleuronat and 5 per cent gum tragacanth. The animals 
were killed after 24 hours by bleeding from the carotid artery, and the exudates were 
collected  in citrated isotonic saline,  centrifuged, and  the sedimented leucocytes re- 
peatedly washed with isotonic sodium chloride to remove the supernatant fluid, which 
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contains  substances of proteinase-inhibitory activity  (3),  presumably derived from 
the serum. Smears of the sediment showed over 90 per cent polymorphonuclear leuco- 
cytes. The leucoproteinase preparations were made by homogenizing  the sediment in 
10 times its volume of distilled  water. No difference was observed in the proteinase 
activity of leucoproteinase derived from the rat and from the cat, or in the effect of 
various inhibitors on this activity. 
Determination  of Proteinase Acti~ty.--Casein  and denatured hemoglobin were the 
substrates  employed. The  initial  proteinolytie  change which  rendered  the  protein 
molecules no longer precipitable by sulfosaficylic and triehloracetie acids was the index 
of proteinolytie activity. 
Casein proteinolysis was determined by incubating a  solution of 1.75 mg./ml, of 
casein 5 in  ~/25  SCrenson phosphate buffer  5 with the various enzyme preparations, 
at 37  ° C. and pH 7.6. The concentration of undigested protein was determined at inter- 
vals by precipitating 1 ml, of digest mixture with 3 ml. of 25 per cent HCI and 2 ml. 
of 20 per cent sulfosalieylic  acid, and immediately  e measuring the turbidity of the 
resulting  suspension  by the  transmission of monochromatic light at  405  mr* wave 
length in a Coleman Junior photoelectric colorimeter. 
The concentrations of proteinolytic enzymes that effected 50 per cent digestion  of 
1.75 mg./ml, of casein in approximately 4 hours were: 
Trypsin  7 (crystalline): 1 ×  101 ~. 
Chloroform-activated serum proteinase: 0.02 ml./ml.(0.015 mg./ml, protein N), 
Serum proteinase precursor: 0.01 ml./ml. (0.018 mg./ml, protein N). This was ac- 
tivated by streptokinase, 0.01 ml./ml. (0.006 mg./ml, protein N), which was added to 
the precursor 20 minutes before addition of inhibitor. 
Leucoproteinase: 0.02 ml./ml. (0.01 mg./ml, protein N). 
Papain (crude,  Difco): 0.003 mg./ml. (0.0002 mg./ml, protein N)., 
Hemoglobin proteinolysis was determined after the method of Anson and Mirsky 
(21) by incubating a solution of 7.6 mg./ml, of denatured hemoglobin at pH 7.3 with 
the various enzyme preparations at 37°C. The concentration of digested protein was 
determined at intervals  by precipitating unaltered  protein with trichloracetic acid, 
and determining the tyrosine(-tryptophane-cysteine) equivalent of the filtrate with 
the phenol reagent. The above concentrations of enzymes effected 20 per cent digestion 
of 7.6 mg./ml, of denatured hemoglobin in approximately 8 hours. 
Serum proteinase was inhibited by the high concentration of urea present in the 
hemoglobin substrate (21), so that for the estimation of hemoglobin proteinolysis by 
serum proteinase the substrate was prepared without urea by adjusting the pH of 
5 Stock solutions  for preparation of digest mixture contained 0.5 per cent casein in 
0.003 N NaOH (pH 8.5), and M/15 NaH2PO~-Na2HPO4 buffer (pH 7.4). 
s Any delay in making the turbidity measurement was accompanied by flocculation 
of the precipitated casein. This occurred most rapidly in the absence of serum proteins, 
a small amount of which delayed the occurrence of flocculation. 
The preparation used contained 50 per cent MgSO4. This could  be removed by 
dialysis, resulting in some diminution in the activity of the preparation, but no altera- 
tion in the effects of the various inhibitors. The molecular weight of trypsin is 34,000 
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Anson's cathepsin substrate  (22)  to 7.8,  and removing the undissolved hemoglobin. 
The concentration of denatured hemoglobin in the digest mixtures which did not con- 
tain urea was 2.5 mg./ml. None of the proteinases hydrolyzed native hemoglobin to 
any appreciable extent. 
Smaller concentrations of the enzyme preparations than recorded above produced 
proportionately less proteinolysis; i.e., in the range of enzyme concentrations employed 
the amount of casein or hemoglobin digested was a linear function of the concentration 
of free enzyme. This  enabled  calculation  of the concentration of free enzyme from 
the determined amount of casein or hemoglobin proteinolysis, and hence the concen- 
tration of enzyme inhibited. 
Solutions  to be  tested for inhibitory activity were buffered with phosphate and 
were exposed to the enzyme for at least 20 minutes at room temperature  before ad- 
dition of the substrate.  The inhibitory activity of the purified inhibitors, and of serum 
and plasma protein fractions, against trypsin, serum proteinase, and papain was essenti- 
ally the same when the substrate  was denatured  hemoglobin (with or without urea) 
as when the substrate was casein. Leucoproteinase, however, was inhibited to a lesser 
degree when the former substrate was employed. The results recorded were those ob- 
tained with casein substrate,  but, with the above exception, comparable results were 
obtained with denatured hemoglobin. In the study of the influence of reducing and 
oxidizing agents on proteinase activity casein was the only substrate employed, as the 
phenol method of determining proteinolysis could not be used in the presence of these 
agents. 
In the analysis of experimental findings the activity of serum proteinase,  leuco- 
proteinase, and papain has been expressed in terms of molar concentration of trypsin 
of equal proteinolytic activity against casein under the conditions of the experiment. 
As is evident from the different effects on these enzymes of the various inhibitors, and 
from their well known differences  in substrate specificities  and other properties, these 
enzymes are distinct, and it is not meant to imply that they have a common chemical 
constituent. Expression of the activity of serum  proteinase, leucoproteinase, and pa- 
pain  in  terms  of concentration of trypsin  of equal  activity has merely provided a 
common measure of enzyme activity and has enabled easier comparison of the effects 
of the various inhibitors.  In comparing the inhibitors the concentrations required to 
inhibit half of the enzyme activity present have been recorded (Tables II and III). 
At 50 per cent inhibition the slopes of the curves (Figs. 1 to 3) are greatest, and inter- 
polation most accurate. 
RESULTS 
A. Proteinase Activity of Plasma Protein Fractions (Table I) 
The proteinolytic activity of the various  plasma  protein  fractions was  de- 
termined  prior to any treatment,  and after treatment  with streptokinase  and 
chloroform.  Untreated  solutions  of  the  plasma  fractions  had  no  appreciable 
proteinase activity against casein. Treatment with streptokinase or with chloro- 
form resulted  in  the  appearance  of proteinase  activity  in  fraction  II +  III, 
and to a  lesser degree in  fraction  I.  Fractions  II,  IV -  1,  IV -  4,  and  V  had 
little or no proteinolytic activity after this treatment.  The proteinase  activity 
of fraction II +III  is believed to be due to fraction III. DAVID GROB  107 
The addition of streptokinase  to fractions I  or II +  III resulted in approx- 
imately twice as much proteinolytic activity as did long standing in the presence 
of  chloroform.  Activation  by  streptokinase  occurred  within  a  few  minutes, 
while  activation  by chloroform required  several  days.  When  sterile  solutions 
TABLE I 
Proteinase Activity of Purified Plasma Fractions after Treatment with Chloroform or Addition 
of Streptokinase 
Chloroform treatment consisted of adding  1/10 volume of chloroform to solutions of the 
plasma  fractions,  which were then shaken  for 2 minutes,  allowed to stand at 24°C. for 1 
week, and the supernatant removed  after centrifuging and added  to the substrate.  Strepto- 
kinase (0.03 ml./ml.)  was added to other solutions of the plasma fractions 20 minutes before 
addition  of the substrate. 
Plasma 
fraction 
II 
II +  III 
IV-I 
IV-4 
V 
Principle  components* 
Fibrinogen  (61 per cent) 
B-Globulin (15 per cent) 
-r-Globulin (8 per cent) 
~,-Globulin (97 per cent) 
B-Globulin (48 per cent) 
-r-Globulin (37 per cent) 
al-Globulin  (89 peer cent) 
B-Globulin (10 per cent) 
a2-Globulin (46 per cent) 
B-Globulin (38 per cent) 
Albumin (95 per cent) 
Protelnase activ- 
ity~ 
After 
addition 
of 
strepto- 
kinase 
0.64 
0.08 
0.98 
0.10 
0.02 
* From the data of Cohn and his associates  (23). 
:~ Expressed in terms of concentration  of trypsin (~¢ X  10  "9) of equal activity. 
of the plasma protein fractions were allowed to stand for 1 week at room tem- 
perature,  under  aseptic  conditions  and  in  the  absence  of  chloroform,  some 
proteinolytic activity could be demonstrated in fraction II +III,  but  much 
less  than  appeared  in  the  presence  of chloroform. 
B. Proteinase-Inhibitory Activity of Purified Inhibitors Obtained from Egg White, 
Pancreas, Soy Bean, and Lima Bean (Figs. 1 and 2, and Table II) 
Study of the inhibition of trypsin by egg white, pancreas, soy bean, and lima 
bean inhibitors confirmed the reports of stoichiometric inhibition (10, 7, 11, 12). 108  PROTEOLYTIC  ENZYMES.  III 
The curves for inhibition  of trypsin by egg white, pancreatic,  and lima bean 
inhibitors  were  compatible  with  inhibition  which  was  reversible  under  the 
conditions of the experiment, while the curve for soy bean inhibitor was com- 
patible  with  equimolar  irreversible  inhibition.  Soy  bean  inhibitor  was  most 
potent,  perhaps because of the  irreversible nature  of the  inhibition.  The ap- 
parent  dissociation  constants  s of  the  compounds formed by combination  be- 
|.0 
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.8 
.7 
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of 
TRYPSIN  .5 
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.5 
.2 
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SOYBEAN 
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Goncenttation  of  InhibHo¢ (M x I0  "s) 
Fzo.  1.  (e) Inhibition of trypsin by soy bean, lima bean, pancreatic, and egg white 
inhibitors. The initial concentration of trypsin was I  ×  10  -9 ~. 
(o) Inhibition of serum proteinase by pancreatic inhibitor. This was similar to the 
inhibition of trypsin by pancreatic inhibitor and is recorded in terms of concentration 
of trypsin of equal activity to the serum proteinase inhibited. The initial concentra- 
tion of serum proteinase was equal in activity to 1 ×  10  -9 ~ trypsin. 
tween trypsin and lima bean, pancreatic, and egg white inhibitors  were, over 
most of the  range of inhibitor concentration studied,  approximately 0.4,  0.6, 
and 0.8  X  10  -~. 
Serum proteinase and crystalline trypsin, in concentrations  of equal activity, 
were equally inhibited  by pancreatic inhibitor,  the  curve of inhibition  being 
compatible with reversible inhibition.  Serum proteinase was also  inhibited  by 
soy bean  and  lima bean  inhibitors,  but  a  somewhat higher concentration  of 
s k =  t(I -  (T -  t)),  where  T  -- concentration of active plus inactive trypsin, t = 
T-t 
concentration of active trypsin, and I  =  concentration of free plus combined inhibitor. 
is from mass action equation (k  =  t  ×  i  Equation  t~'  where i  =  concentration of free 
1  k  )  inhibitor and ti  =  concentration of trypsin-inhibitor compound  , following substitu- 
tion for i( =140 and ti (=T-t). DAVID  OROB  109 
the former and a  much higher concentration of the latter  were required  than 
was  the  case  for  pancreatic  inhibitor.  Serum  proteinase  was  only  slightly 
inhibited by relatively high concentrations of egg white inhibitor.  The inhibi- 
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FIG.  2. Inhibition  of  serum  proteinase  (e  •),  leucoproteinase 
(•  --•),  and  papain  (• ..........  •)  by  pancreatic,  soy  beanl 
lima bean, and egg white inhibitors. The initial concentration of each enzyme was equa, 
in activity to 1  X  10  "9 ~  trypsin. 
TABLE II 
Proteinase-lnhibitory  Activity of Purified Inhibitors Obtained  from Pancreas, Soy Bean, Lima 
Bean, and .Egg Whlte 
The initial  concentration of  enzyme was 1 X  10  -9  ~ trypsin,  and serum proteinase,  leueo- 
proteinase, and papain of equal activity. 
Enzyme 
Trypsin ................. 
Serum proteinase ....... 
Leucoproteinase ........ 
Papain ................. 
Concentration of inhibitor (~) that inhibited 0.5 X  10  "~ K tryl~sln and 
serum proteinase, leucoproteinase, and paI~in of equal actLvity 
Pancreatic  Soy bean inhibi-  Lima  bean inhibi-  Egg white inhibi. 
inhibitor  tor  tot  tar 
1.1 X  10  -9 
1.1 X  10  -9 
>10-5 
> 10-  5 
0.5 x  10` 9 
4  X  10-  8 
>10-4 
> 10-  ~ 
0.8 X  10` 9 
3  X  10-  e 
>10-4 
> 10-4 
1.3 x  10  `9 
> 10`  4 
> 10`4 
> 10-4 
tion  of serum  proteinase  by any of the purified  inhibitors  was  independent 
of the mode of activation of the serum proteinase  (by chloroform or  by strep- 
tokinase). 
Leucoprotelnase  and papain were inhibited only very slightly by the purified 
inhibitors,  even in relatively high concentrations. The egg white inhibitor had 
the  least  inhibitory  activity. B~ "~  ~  ~  .... =6  CONOE.  ///~  ~  ....  ~. 
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CONGENTRATION  OF  INHIBITOR  (Grams  /  Liter) 
FzG. 3 b 
FzGs. 3 a--d.  •  e,  inhibition  of  trypsin  (Fig.  3 a),  leucoproteinase 
(Fig. 3 b), serum proteinase (Fig. 3 c), and papain (Fig. 3 d) by serum  (or plasma), 
"reconstituted plasma proteins" (RPP), and plasma protein fractions I, II, II +III, 
IV - 1, IV - 4, and V. Where a protein fraction is not recorded the inhibitory activity 
was negligible. The concentration of serum is recorded as the concentration of total 
protein in the serum, which is almost the same concentration as that of the reconsti- 
tuted plasma proteins. 
o ........  o, inhibition of the above enzymes  by the  concentration  of plasma 
protein  fraction  (circled)  present  in  the  concentration  of  serum  indicated by  the 
abscissa. 
The initial concentration of enzyme was 1  X  10  -9 ~  trypsin, and concentrations of 
leucoproteinase, serum proteinase, and papain of equal activity. 
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C.  Proteinase-InMbitory  Activity  of Serum  and  of Purified  Plasma  Fractions 
(Figs. 3 a - d, and Table III) 
Serum,  even in high dilution, inhibited all the proteinases studied.  Trypsin 
was inhibited by the lowest concentration of serum,  while  leueoproteinase  re- 112  PROTEOLYTIC  ENZYMES.  HI 
quired  slightly  more  serum,  and  papain  and  serum  proteinase  considerably 
more. The inhibitory activity of plasma was equal to that of serum. 
Plasma prolein fractions  IV -  1 and IV -  4,  even in high dilution,  inhibited 
all the proteinases studied, except that the inhibitory activity of fraction IV- 
4  against serum proteinase was relatively slight.  Much higher concentrations 
of fractions I  and V  were required  to inhibit  the proteinases,  while fractions 
II and II +  HI had only slight inhibitory activity even in high concentration. 
Subfraction IV - 6 - 2 had nearly as much inhibitory activity against the pro- 
teinases as did its parent fraction IV - 4, while subfraction IV - 8 had considera- 
bly less. The curves for inhibition  of any of the proteinases by serum and by 
TABLE  III 
Proteinase-Inhibitory Activity of Serum and of Plasma Protein Fractions 
The initial concentration of enzyme was 1 X  10  -9 ~ trypsin and serum proteinase, leuco- 
proteinase, and papain of equal activity. 
Enzyme 
Trypsin ................. 
Leucoproteinase  .......... 
Papain .................. 
Serum proteinase ......... 
Concentration  of serum and of plasma protein fractions 
that inhibited 0.5 X 10-* K trypsip and leucoproteinase, papain, and 
serum proteinase of equal activity 
Plasma fraction 
i  I  Iv-1  I  Iv-,  I  v 
Reconsti-  I 
tuted  Whole serum  plasma 
proteins 
Gm/1  •  '-  ml./ml  of protein 
X  lO-S  X  10-= 
i__ 
Gm./l. X 10  -s 
>500 
300 
>500 
500 
3  1  500 
2  5  >500 
80  120  >500 
65  >500  500 
12 
36 
300 
310 
1  I  0.01 
4  0.06 
38  o. 83 
82  1.17 
I 
the plasma protein fractions were compatible with inhibition which was revers- 
ible under the conditions of the experiment. 
The sensitivity of the proteinases to inhibition by fractious IV -  1 and IV - 
4  was  in  general  similar  to  their  sensitivity  to  inhibition  by  whole  serum: 
trypsin and leucoproteinase were inhibited by smaller concentrations of these 
fractions than  were papain and serum proteinase.  The concentration  of frac- 
t/on IV - 1 or IV - 4 required for inhibition of any of the proteinases was roughly 
equal to the concentration of total protein in serum that gave equal inhibition, 
except for fraction IV - 4 against serum proteinase. 
The sum of the proteinase-inhibitory activities of the plasma protein frac- 
tions,  in  concentrations similar to those present in plasma, was less than  the 
inhibitory  activity  of  whole  serum  (or  plasma).  When  the  plasma  protein 
fractions were mixed in proportions similar to those present in plasma the in- 
hibitory activity of the resulting "reconstituted plasma proteins" against any DAVID  GROB  113 
of the proteinases was approximately equal  to  the  sum  of  the  inhibitory ac- 
tivity of the constituent plasma fractions, but was only -~ to ¼ that of whole 
serum (or plasma)  containing an equal concentration of proteins. The contri- 
butions of the various plasma fractions to the inhibitory activity of the "re- 
constituted plasma proteins" varied with each enzyme. Fractions IV -  1 and 
IV - 4 had over 100 times more inhibitory activity against trypsin and leuco- 
proteinase than did fraction V, so that the inhibitory activity of the plasma 
proteins against  these enzymes was  due almost entirely to  fractions  IV -  1 
and IV - 4, even though the concentration of fraction V in the serum (or plasma) 
is 3 times that of fractions IV - 1 and IV - 4 combined. With respect to papain 
and serum proteinase, on the other hand, fractions IV -  1 and IV - 4 had less 
than 10 times the inhibitory activity of fraction V, so that fraction V made a 
slightly greater contribution to the inhibitory activity of the plasma proteins 
against these enzymes than did fraction IV -  1 or IV - 4. Fractions I, II, and 
III did not contribute significantly to the inhibitory activity of the plasma pro- 
reins against any of the proteinases. 
The inhibition of serum proteinase by serum or by any of the plasma protein 
fractions was independent of the enzyme precursor employed (serum protein- 
ase precursor (19), or fraction II -{- III), or of its mode of activation (by chloro- 
form or streptokinase). The degree of inhibition of serum proteinase by serum 
(or plasma)  did not increase when  the  concentration  of  substrate  was  de- 
creased from 1.75  rag.  per cent to  1.0  and 0.5 rag.  per cent, which suggests 
that over this limited range of substrate concentration the components of serum 
that  inhibited serum proteinase did not compete with  the substrate  for the 
enzyme. 
D. Effect of Heat on Polypeptide and Protein Protelnase  Inhibitors 
Pancreatic,  serum  "polypeptide,"  and  egg  white  inhibitors  ,  when  tested 
against  trypsin, have been found to be relatively heat  stable at neutral pH 
(6,  9,  10),  while soy bean  inhibitor has been found  to  be heat  labile above 
90°C. (11). Lima bean inhibitor resembled pancreatic and egg white inhibitors 
in being relatively heat stable when tested against trypsin and serum protein- 
ase after being heated at 100oC. for 10 minutes, while soy bean inhibitor was 
heat labile when tested against these enzymes (Table IV). 
Serum,  "reconstituted plasma  proteins," and  fractions IV -  1 and  IV -  4 
were heat labile: heating at 100°C.  for 10 minutes greatly diminished (but did 
not entirely destroy)  their inhibitory activity against any of the proteinases 
(Table IV).  It is of interest that the addition of a  small amount of serum or 
serum albumin  to pancreatic and serum "polypeptide" inhibitors caused the 
latter substances  to lose their heat stability as  inhibitors  of trypsin  (9)  and 
(for pancreatic inhibitor)  of serum proteinase (Figs. 4 a  and 4 b). CONCEN- 
TRATION 
OF 
SERUM 
PROTEINASE 
INHIBITED 
(in  conc. 
of 
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(M xlO  "S) 
of equol 
activity) 
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.8 
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activity)  .....  4  FR.X 
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FIG. 4  b 
FxGs. 4 a and b. Increase in the heat lability of pancreatic inhibitor (tested against 
serum proteinase) by serum  (Fig. 4 a), and by fraction V  (Fig. 4 b). The initial con- 
eentration of serum proteinase was equal in activity to 1 X  10  -9 trypsin. 
•  l•,  inhibition of serum proteinase by pancreatic inhibitor. 
x-  x, inhibition of serum proteinase by heated* pancreatic inhibitor. 
•  ........  @, inhibition of serum  proteinase by serum  (Fig. 4 a)  or fraction V 
(F~. 4 b). 
x ........  x, inhibition of serum proteinase by heated* serum (Fig. 4 a) or frac- 
tion V (Fig. 4 b). 
o  o,  inhibition of serum proteinase by pancreatic inhibitor and  serum 
(Fig. 4 a) or fraction V (Fig. 4 b). 
®  ~, inhibition of serum proteinase by pancreatic inhibitor heated* in 
the presence of serum (Fig. 4 a) or fraction V  (Fig. 4 b). 
* Heated in solution at 100°C. for 10 minutes. 
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TABLE IV 
The Influence of Heo~ on Protein and Polypeptide Proteinase Inklbi:ors (Heated in Solution at 
IO0°C. for  10 Minutes 
Inhibitor 
I 
!Concentration 
i  of inhibitor  ! 
! 
! 
I 
'an~tic inhibi-  i 
tor.  !  lO-'SM 
oy bean inhibi-  i 
tor.  l  " 
,ima bean inhlbi-  ! 
tor .....  i 
;gg white inhibitor, i  " 
;erum~.  i  0.05 gm./1. 
Leconstituted  I 
plasma proteins.. !  " 
'raction IV-1  '  " 
'ractlon  IV-4  ...... i  " 
Trypsin*  Leucopro- 
Inhibited  teinase* 
(~ X  10"*)  Inhibited 
.'Ik  x" 
0.93 O. 8¢ 
1.000.1~ 
0.95 0.93 
0.93 0.53 
0.88 0.08  D.90 0.25 
0.87 0.07 D.85 0.2fl 
0.82 0.18 0.91 0.33 
~.85 0.09 0.88 0.30 
I 
Concentration 
of inhibitor 
lO-SM 
lO-e~ 
lO-SM 
O. 20 gin./1. 
cc 
c( 
Serum  Papain* 
proteinase*  Inhibited 
Inhibited 
m  m  i~ 
i 
I 
0.92 0.80  I 
I 
0.83 0.30 
0.88 0.6O  I 
0.73 0.170.92 0.2~, 
0.4ff 0.10 0.4C ~.1.' 
0.8410.05 0.91  D.3( 
0.1.~ D.030.74  ~).2( 
* Initial concentration  of enzyme was 1 X  10  -s x  trypsin, and leucoproteinase,  serum 
proteinase,  and papain of equal activity. Concentration  of the latter enzymes is recorded as 
concentration  of trypsin (M X  10  -s) of equal activity. 
Concentration  of serum is recorded in terms of concentration  of serum protein. 
E. Proteinase-Inkibitory Activity of Reducing and Oxidising Agents 
Reducing and oxidizing agents,  in very high concentration,  inhibit  trypsin 
and leucoproteinase (5). For trypsin (~ X  10-9) the molar ratio of reducing or 
oxidizing agents  to enzyme necessary to diminish  enzyme activity by 50 per 
cent was approximately  10T:I. Similar high concentrations of reducing and ox- 
idizing agents were required  to inhibit serum proteinase activity, as indicated 
by casein proteinolysis,  while  lower concentrations  had no appreciable  effect 
(Table  V).  The concentrations  of oxidizing  agents  that  were  inhibitory  were 
sufficient to produce protein denaturation,  but the reducing agents  that were 
studied are not protein denaturants  (24), so that some observations have been 
made to attempt  to elucidate  their  possible  mode of action. 
There was no correlation between the inhibition of serum proteinase activity 
by different reducing agents and their ability to reduce a given oxidizing agent 
(e.g. sodium  2,6-dichlorophenol indophenol,  Fig.  5).  On the other hand  there 
did appear to be a  rough correlation between the degree of inhibition by some 
reducing agents  and  the level of EMF  measured potentiometricaUy  (Fig.  5). 116  PROTEOLYTIC ENZYMES. III 
However, a  direct relation between inhibition of serum proteinase activity by 
these reducing agents and  the level of EMF is not proved, particularly since 
under the conditions of the experiment the reducing agents are not components 
TABLE  V 
Inhibitory  Effect of High Concentrations of Reducing and Oxidizing  Agents on the Activity of 
Serum Proteinase  (Chloroform-Activated) 
Serum proteinase activity is expressed as concentration of trypsin  (u  ×  10-9) of equal 
activity. The initial concentration was equal in activity to I  ×  10  -9 M  trypsin. 
Agent  Concentration of agent  Serum proteinase  inhibited 
(x X  1o'~) 
Glutathione 
Cysteine 
Ascorbic acid 
Sodium thioglycollate 
Sodium cyanide 
Sodium hypochlorite 
Hydrogen peroxide 
1.0 
2.8 
4.9 
7.3 
9.8 
13.2 
2.0 
4.1 
6.3 
8.3 
4.5 
9.0 
12.3 
35.1 
70.2 
94.7 
4.1 
0.1 
1.0 
4.4 
8.8 
27.0 
0 
0.18 
0.38 
0.54 
0.58 
0.70 
0 
0.26 
0.44 
0.65 
0.05 
0.30 
0.36 
0.16 
0.40 
0.46 
0.39 
0 
0.70 
0 
0.10 
0.42 
of strictly reversible oxidation-reduction  systems.  This is emphasized by the 
finding that high concentrations of sodium cyanide, a  reducing agent in a  dif- 
ferent  category  than  the  others,  inhibited  serum  proteinase  activity  even 
though this  compound did not alter the level of EMF  of the digest mixture 
and did not reduce sodium 2,6-dichlorophenol  indophenol. 
The degree of inhibition  of serum proteinase by reducing agents  (e.g.  glu- DAVmGgOB  117 
tathione)  did not  increase  when  the  concentration  of casein  was  decreased. 
Although this suggests that, in the range of concentration studied, the reducing 
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FIG. 5.  Left.  Lack of correlation between the inhibition of  serum proteinase ac- 
tivity by different reducing agents and their ability to reduce a given oxidizing agent. 
(This "reducing capacity" is expressed as cubic centimeters of 0.0005 ~  sodium 2,6- 
dichlorophenol  indophenol dedorized by !  ee. of digest mixture at pH 7.4 within 15 
seconds.) 
Right.  Rough correlation between the inhibition of serum proteinase activity by 
some reducing agents and their level of EMF measured potentiometricaUy in miUiC 
volts by the Cambridge electron ray pH meter ("reducing activity"). 
The initial concentration of serum proteinase was equal in activity to  1  X  10  "-g 
u trypsin. Straight lines have been drawn through or near the various points for pur- 
poses of comparison, although S-shaped curves would be more appropriate. 
TABLE VI 
Prevention or Rewrsal of Glutathione Inhib~on of Serum Proteinase by the Addition of Potassium 
Ferricyanlde  2  Hours  after the Onset of Digestion 
The initial concentration of glutathione was 7.3 X  10-8~x. Serum proteinase activity is 
expressed as concentration of trypsin (M X 10  -9) of equal activity. The initial concentration 
of serum proteinase was equal in activity to 1 X 10-9u trypsin. K ferricyanide, in the  con- 
centrations employed, did not accelerate proteinolysis in the absence of glutathione. 
Concentration of K ferticyanide 
(~ X 101) 
0 
0.9 
1.8 
3.1 
Calculated active glutathione 
after addition of K ferricyanide 
(~ X lO-t) 
7.3 
6.4 
5.5 
4.2 
Serum proteinase inhibited 
0.54 
0.44 
0.30 
0.22 
agents did not compete with the substrate for the enzyme, it does not exclude 
alteration of the substrate by the reducing agents. As would be expected, heat- 
ing the reducing agents at 100°C.  for l0 minutes did not alter their inhibitory 
activity,  reducing  capacity,  or reducing  potential.  Reducing  agents  had  ap- 118  PROTEOLYTIC  ENZYMES, HI 
proximately the same inhibitory effect on streptokinase-activated serum pro- 
teinase as  on  the  chloroform-activated enzyme, but  oxidizing agents  had  a 
greater effect on the former. This may have been due to the inhibitory action 
of oxidizing agents on streptokinase (25)  before maximal activation of serum 
proteinase precursor had occurred. 
The inhibition of serum proteinase activity by reducing agents (e.g.  gluta- 
thione)  could be prevented  or reversed  by oxidizing agents  (e.g.  potassium 
ferricyanide) (Table VI). The suppression of glutathione effect by ferricyanide 
appeared to be a  stoichiometric reaction. 
In contrast to the inhibition by high concentrations of reducing agents of 
serum proteinase, leucoproteinase, and trypsin is the activation of papain by 
these substances (even in low concentration) (18).  The activation of papain is 
believed to be due to the reduction of inactive disulfide to active sulfhydryl 
groups (18),  though the mechanism of action of cyanide in this regard is not 
clearly understood (26).  Organic mercurial compounds that are potent inhibi- 
tors of sulfhydryl enzymes such as papain (18),  e.g. benzyl mercuric chloride 
and p-tolyl mercuric chloride, in concentration of 1  X  10-~,  had no effect 
on  the activity of serum proteinase.  They were likewise without significant 
effect on the activity of trypsin or leucoproteinase (5). 
DISCUSSION 
Serum  Proleinase 
Serum proteinase normally exists in an inactive precursor state and can be 
activated slowly by chloroform, other organic solvents and other agents, and 
rapidly by streptokinase (14).  The mechanism of activation is not yet clearly 
understood. Evidence exists that activation by streptokinase is catalytic, and 
that the slower activation by chloroform may be due to the removal by the 
chloroform of serum proteinase inhibitors, followed by the  autocatalytic  ac- 
tivation of the precursor (14, 27). 
Proteinase  activity has  previously  been  demonstrated  in  plasma  protein 
fractions I, II +III  (especially III- 2), and IV - 1 after treatment with chloro- 
form  (28,  29).  In  the  experiments  described  above  even  greater proteinase 
activity resulted from the activation of fractions I  and II +  III by strepto- 
kinase  than  by chloroform. The  lesser  activity of the  chloroform-activated 
fractions may have been due to incomplete activation, autodlgestion of enzyme, 
or denaturation of some of the enzyme or its precursor by chloroform. 
Fraction II +III  did not have appreciable inhibitory activity against serum 
proteinase. Therefore, the inactivity (prior to activation) of the serum protein- 
ase precursor present in this fraction was not due to the presence of free pro- 
teinase inhibitors, and the activation by streptokinase and chloroform of  the 
enzyme in this fraction was not due to the removal of such inhibitors. Although DAVID  GROB  119 
some spontaneous activation of the proteinase precursor in fraction II +III 
could be demonstrated after long standing under aseptic conditions, this acti- 
vation was much less than occurred in the presence of chloroform. This suggests 
that chloroform may not only permit  the  spontaneous  activation  of serum 
proteinase precursor  by removing proteinase inhibitors  when  present  (14), 
but may also increase this activation in an as yet undefined way. 
Proteinase Inhibitors  in tke Serum 
The crude "albumin" fraction of the serum, as prepared by ammonium sul- 
fate precipitation, has long been associated with the inhibitory activity of the 
serum against trypsin (30) and against serum proteinase (14). Study of purified 
protein fractions revealed that protein fractions IV- 1 and IV - 4 had greatest 
inhibitory activity against the proteinases studied, fractions V  (albumin) and 
I  had much less inhibitory activity, and fractions II and II +  IH had little 
or none. Fractions IV - 1 and IV - 4 were especially potent as inhibitors of tryp- 
sin and leucoproteinase, and were responsible for almost all the inhibitory ac- 
tivity of the plasma proteins against these enzymes. The inhibitory activity 
of fractions IV  -  1 and IV-  4  against serum proteirmse and papain was less 
marked,  although,  except for  the  slight activity of fraction IV  -  4  against 
serum proteinase, greater than that of fractions V and I. Because of its rela- 
tively high concentration in the serum fraction V made a slightly greater con- 
tribution to the inhibitory activity of the plasma proteins against serum pro- 
teinase and papain than did fraction 1V - 1 or IV - 4. Fractions I, II, and III 
were relatively  unimportant  with  respect  to  proteinase-inhibitory  activity 
exerted by  the  plasma  proteins. 
The components of fractions IV -  1 and IV -  4  responsible for their pro- 
teinase-inhibitory activity have not been determined. According to the studies 
of Oncley, Scatchard, and Brown (31) 89per cent of fraction IV - 1 consists of 
ax-globulin (lipoprotein) of molecular weight  200,000  and  10 per cent O-glo- 
bulin of molecular weight 90,000,  while 46 per cent of fraction IV - 4 consists 
of as-globulin of molecular weight 300,000 and 38 per cent B-globulin of molec- 
ular weight 90,000.  H the molecular weight of the components of these  frac- 
tions responsible for their proteinase-inhibitory activity is  90,000  or above, 
the molar concentration that inhibited 0.5 X  10  -9 M trypsin would be less than 
1 X  10  "-9 M of protein of fraction IV - 4 and less than 3  X  10  --~ M of protein 
of fraction IV -  1. This suggests the possibility of stoichiometric reaction be- 
tween components of these fractions and trypsin. 
The plasma proteins, as "reconstituted" from the purified plasma protein 
fractions, had approximately 8 to 25 per cent of the proteinase-inhibitory ac- 
tivity of whole serum (or plasma)  containing an equal concentration of pro- 
reins. The remaining proteinase-inhibitory activity of the serum may be due 
to non-protein inhibitory substances in the serum, and to any loss of inhibitory 120  PROTEOLYTIC  ENZYMES.  HI 
activity  of the plasma  protein fractions  that  may  have  occurred  during  the 
process of fractionation  and purification.  There is evidence for the presence of 
non-protein proteinase inhibitors in the serum, the most potent being a crystal- 
lizable compound which may be a polypeptide (8,  9). Lesser degrees of inhibi- 
tory activity are exerted by ~-tocopheryl phosphate  (32) and even less by re- 
ducing substances,  such as ascorbic acid, cysteine, and glutathione  and other 
cysteine peptides.  Heparin does not contribute significantly to the proteinase- 
inhibitory  activity  of the  serum  (9). 
The possibility exists that the plasma protein fractions may have contained 
small  amounts  of  the  serum  "polypeptide"  inhibitor.  However,  if  this  sub- 
stance were responsible for all the trypsin-inhibitory  activity of fractions IV - 
1 and  IV -  4, it would have  to constitute  approximately  5  per cent of these 
protein fractions.  In addition,  there is a striking difference between the action 
of the serum  "polypeptide" inhibitor and of whole serum against at least one 
enzyme (chymotrypsin)  (8), indicating  that the "polypeptide" is not the only 
important  inhibitor  in the serum. 
The  heat  lability of the proteinase-inhibitory  activity of the serum is due, 
at least in part,  to the heat lability of the proteinase-inhibitory activity of the 
serum proteins,  but is in  contrast  to the heat stability of the purified  serum 
"polypeptide" inhibitor  (9). A parallel situation exists with respect to dialyza- 
billty.  However, the presence of serum albumin  or of whole serum alters  the 
properties  of  the  serum  "polypeptide"  inhibitor  (as  it  does  the  pancreatic 
polypeptide inhibitor)  in such a  way as to make it heat labile (9). It is of in- 
terest  in  this  regard  that  plasma  polypeptides  are  said  to  be  normally  ad- 
sorbed  to plasma proteins  (33). 
Comparative Acti~ties of the Proteinase Inhlbitors 
Comparison  between the proteinase-inhibitory effects of the inhibitors stud- 
ied is made difficult by inability to determine  the  molar  concentration  of im- 
pure substances of unknown molecular weight,  such as serum proteinase,  leu- 
coproteinase, crude papain, and the pmteinase inhibitors in the various plasma 
fractions. However, expressing the concentrations of the above enzyme prepar- 
ations in terms of molar concentration of trypsin of equal activity has enabled 
some comparison  to be made between the effects of the purified inhibitors on 
these enzymes (Table II).  If the molecular weight of the plasma protein inhib- 
itors is assumed  to be 90,000 or above,  their  molar  concentrations  (×  10  --9) 
would be approximately equal to, or less than,  those indicated by the figures in 
Table III,  and some comparison may also be possible between the inhibitory 
activities of the plasma protein  inhibitors  (Table III)  and  of the purified  in- 
hibitors  (Table II). 
Of the enzymes studied,  trypsin was the most sensitive to inhibition,  being 
inhibited  (stoichiometricaUy)  by low concentrations  of soy bean,  pancreatic, DAVmGROB  121 
lima  bean,  and egg white inhibitors,  by low concentrations  of fractions  IV - 
I and IV - 4 (possibly stoichiometrically)  and serum, and by higher concentra- 
tions of fraction V.  Serum proteinase was inhibited by low concentrations  of 
pancreatic inhibitor, and by higher concentrations of soy bean inhibitor, serum, 
fractions IV -1, V,  and I, and lima bean inhibitor.  Leucoproteinase was inhib- 
ited by low concentrations of serum, and  fractions  IV -  1 and IV - 4,  and  by 
higher  concentrations  of fraction  I.  Papain  was inhibited  by low concentra- 
tions of mercurial sulfhydryl inhibitors,  and by higher concentrations of serum 
and fractions IV -  1 and IV - 4. 
Of the inhibitors  studied, serum and fraction IV -  1 were the least specific, 
inhibiting  all four proteinases.  Egg white inhibitor  was the most specific, in- 
hibiting  only trypsin. The  reducing  and  oxidizing  agents  required  such high 
concentrations  for their  inhibitory activity against  trypsin,  serum proteinase, 
and leucoproteinase  that  their  inhibitory  activity appears  to be non-specific, 
and  perhaps  the  result  of action  on  substrate  rather  than  on  the  enzymes. 
Inhibition  by mercurial  sulfhydryl inhibitors  was limited to papain,  which is 
thus seen to be the only enzyme of the proteinases studied which contains free 
sulfhydryl  groups  essential  for  its  activity. 
Of the enzymes studied,  only trypsin was in pure form. The other enzyme 
preparations  may  be mixtures  of enzymes,  and  may  contain  inhibitors  and 
activators.  It is therefore necessary to interpret  the results as applying to the 
enzyme  trypsin,  and  to  the  crude enzyme preparations  of serum proteinase, 
leucoproteinase,  and papain.  In addition,  the method employed furnished in- 
formation with respect to the inhibition of the proteinase activity of these en- 
zymes on the substrates  casein and  denatured  hemoglobin.  Information  con- 
ceruing inhibition of their proteinase activity on other substrates, and of their 
peptidase  activity,  awaits  further  study.  Finally,  only in  the  case of the  in- 
hibition of trypsin by pancreatic, egg white, soy bean and lima bean inhibitors 
has a direct effect of inhibitor on enzyme been proved (7, 10-12). In the other 
instances this can only be inferred from the observed effect of the inhibitors on 
enzyme activity. 
Physiological Significance of the Proteinases and Tkeir Inkibitors 
Serum proteinase is capable of exerting a  thromboplastic  action which may 
be important  in  blood coagulation  (34).  Coagulation  is  inhibited  by several 
inhibitors  of serum proteinase,  including  serum  "polypeptide"  inhibitor  (9), 
pancreatic  inhibitor  (9,  15), soy bean inhibitor  (16), fraction IV -  1 (but also 
IV -  4)  (35),  and  high  concentrations  of reducing  and oxidizing  agents  (36). 
Serum proteinase may play a part in fibrinolysis and clot retraction,  which are 
also inhibited by pancreatic and soy bean inhibitors  (14, 37). Serum proteinase 
may play a  r61e in the release of protein-bound  histamine  and heparin  in an- 
aphylactic and peptone shock (17, 38), which are said to be inhibited by soy 122  PROTEOLYTIC  ENZYMES.  III 
bean inhibitor (39). Alterations in the proteinase and proteinase-inhibitory ac- 
tivity of the serum have been reported in a variety of clinical  conditions, in- 
cluding anaphylaxis, high fever, anemias,  pregnancy, many chronic debilitating 
diseases (references  cited in reference  9), and malignant  tumors (40). 
Leucoproteinase plays an  important  part  in  the dynamics of inflammatory 
processes (3). The products of the hydrolysis of protein by leucoproteinase or 
trypsin have been found to stimulate bacterial growth and to directly and in- 
directly inhibit sulfonamide action. Bacterial growth is inhibited by pancreatic 
trypsin  inhibitor  even  in  the  absence of non-bacterial  proteolytic enzymes, 
perhaps  as a  result of inhibition  of bacterial proteinases  (5,  9). 
Trypsin is important  in intestinal  proteolysis. The  release of trypsin into 
the peritoneal cavity in pancreatitis may account for many of the lesions  that 
are observed in this disease.  Trypsin and papain have both been extensively 
used in the preparation of protein digests for oral and parenteral administra- 
tion,  for bacterial media, and for other medical and industrial purposes (41). 
There  are  numerous  other  proteolytic  enzymes  and  enzyme  systems  of 
physiological  and biological  importance.  These include the cathepsins, serum 
and  tissue peptidases, skin  protease (42),  necrosin  (a proteolytic enzyme im- 
portant  in inflammation)  (43),  and bacterial and mold proteases.  The  blood 
pressure regulatory mechanism is thought by many to include a  kidney pro- 
teinase  (renin)  and  a  serum protease  (a  polypeptidase  known  as  hyperten- 
sinase)  (44),  Study of the effect on  these enzymes of serum,  plasma protein 
fractions,  and purified  trypsin inhibitors may prove of interest. 
S~qtf~ARY 
1. Serum proteinase precursor was found in plasma protein fractions  I and 
Ill  of  Cohn. Inhibitors  of  serum proteinase, Icucoproteinase, trypsin,  and pa- 
pain were found in  fractions  IV  -  I and  IV -  4,  and  to  a lesser  extent  in  fractions 
V and I. 
2.  Pancreatic, soy bean, lima  bean, and egg white inhibitors inhibited tryp- 
sin stoichiometrically. Pancreatic inhibitor had comparable inhibitory activity 
against  serum proteinase;  soy bean  inhibitor  had  somewhat less,  lima  bean 
inhibitor even less, and egg white inhibitor very little. None of these inhibitors 
appreciably  inhibited  leucoproteinase  or papain. 
3.  Serum and fractions IV -  1 and IV - 4 had marked inhibitory activity 
against trypsin and leucoproteinase, and somewhat less against serum proteino 
ase and papain. The inhibitory activity of the plasma proteins against trypsin 
and leucoproteinase was due almost entirely to fractions IV -  1 and IV -  4; 
against serum proteinase and papain fraction V was slightly more important. 
The  "reconstituted  plasma proteins" accounted  for 8  to 25 per  cent  of the 
proteinase-inhibitory activity of whole serum or plasma. 
4.  The  proteinase-inhibitory  activity  of serum,  plasma  protein  fractions, DAVID GROB  123 
and soy bean inhibitor was heat labile, while that of pancreatic, lima bean, 
and egg white inhibitors was relatively heat stable. 
5.  Reducing  and  oxidizing agents,  in  very  high  concentration,  inhibited 
serum proteinase,  as well as  trypsin and leucoproteinase. These  proteinases 
were  not influenced by mercurial  sulfhydryl inhibitors,  indicating that  free 
sulfhydryl groups do not play an important part in their activity. 
It is a pleasure to acknowledge the technical assistance of Mrs. Martha Jaffe and 
Miss A. Dudley Field in these studies. 
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